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Prevention of muscle wasting and osteoporosis: the value of
examining novel animal models
Beau D. Reilly* and Craig E. Franklin
ABSTRACT
Bone mass and skeletal muscle mass are controlled by factors such
as genetics, diet and nutrition, growth factors and mechanical stimuli.
Whereas increased mechanical loading of the musculoskeletal
system stimulates an increase in the mass and strength of skeletal
muscle and bone, reduced mechanical loading and disuse rapidly
promote a decrease in musculoskeletal mass, strength and ultimately
performance (i.e. muscle atrophy and osteoporosis). In stark contrast
to artificially immobilised laboratory mammals, animals that
experience natural, prolonged bouts of disuse and reduced
mechanical loading, such as hibernating mammals and aestivating
frogs, consistently exhibit limited or no change in musculoskeletal
performance.What factors modulate skeletal muscle and bonemass,
and what physiological and molecular mechanisms protect against
losses of muscle and bone during dormancy and following arousal?
Understanding the events that occur in different organisms that
undergo natural periods of prolonged disuse and suffer negligible
musculoskeletal deterioration could not only reveal novel regulatory
factors but also might lead to new therapeutic options. Here, we
review recent work from a diverse array of species that has revealed
novel information regarding physiological andmolecular mechanisms
that dormant animals may use to conserve musculoskeletal mass
despite prolonged inactivity. By highlighting some of the differences
and similarities in musculoskeletal biology between vertebrates that
experience disparate modes of dormancy, it is hoped that this Review
will stimulate new insights and ideas for future studies regarding the
regulation of atrophy and osteoporosis in both natural and clinical
models of muscle and bone disuse.
KEY WORDS: Aestivation, Apoptosis, Hibernation, Immobilisation,
Protein synthesis, Sclerostin
Introduction
The vertebrate musculoskeletal system executes an array of
important functions, including facilitating movement and
breathing, providing a structure to support an upright stance and
protecting internal organs. Bone often serves as a reservoir for
calcium and, in some animals, is also the predominant site of
haematopoiesis (Renkema et al., 2008). Skeletal muscle accounts
for >80% of glycogen storage and is crucial for glucose homeostasis
and the regulation of metabolism (Jensen et al., 2011).
Skeletal muscle and bone mass are influenced by various factors,
including diet and nutrition, genetics, hormones, growth factors and
mechanical stimuli (Goodman et al., 2015). The mass of bone and
skeletal muscle is maintained in proportion to the mechanical
loading experienced by the musculoskeletal system. For example,
resistance training leads to an increase in muscle size and bone
mineral density, which is associated with improved musculoskeletal
fitness (English et al., 2014; Ryan et al., 2004). In contrast,
conditions of low mechanical load and disuse, such as cast
immobilisation, prolonged bed rest and hindlimb unloading,
promote significant losses of both skeletal muscle and bone
mineral mass and strength (Bloomfield, 1997; Bodine, 2013a;
Veitch et al., 2006). The deleterious effects of prolonged
musculoskeletal disuse (i.e. muscle atrophy and osteopenia or
osteoporosis; see Glossary) appear to be common to the majority of
vertebrates studied, but the degree of loss is variable and dependent
on factors such as age, the extent of disuse, and muscle fibre or bone
type composition (Hudson and Franklin, 2002b; McGee-Lawrence
et al., 2008).
It is well known that numerous animals naturally enter prolonged
periods of dormancy (e.g. hibernation and aestivation; see Glossary)
to survive unfavourable environmental conditions; these periods
usually involve prolonged inactivity and fasting. Remarkably,
hibernating mammals and aestivating frogs have been shown to
exhibit negligible or no loss of musculoskeletal mass and strength,
despite the fact that they experience natural periods of extended
inactivity and starvation that can, in extreme cases, last for years
(Cotton, 2016; Hudson and Franklin, 2002b; James, 2010; McGee-
Lawrence et al., 2008). The physiological adaptations of hibernating
and aestivating animals may provide insight into why inactivity-
induced muscle and bone loss occurs relatively rapidly in other
vertebrate species, and might suggest novel potential treatments for
these conditions in humans. Treatment options for muscle disuse
atrophy and osteoporosis are currently limited, with rehabilitative
strength training proving to be the most effective method to restore
musculoskeletal mass; however, long periods of rehabilitation are
necessary to restore muscle, bone and locomotor performance
following artiﬁcial immobilisation in non-hibernating mammals.
This Review will firstly provide an overview of musculoskeletal
disuse in vertebrates by describing the defining features of disuse-
induced muscle atrophy and osteoporosis, summarising the recent
developments in understanding the potential underpinning
mechanisms. We then focus on the exciting and novel
physiological and cellular strategies used by dormant animals to
preserve musculoskeletal integrity. We conclude by discussing
potential future directions: it is clear that additional whole-animal
and systems biology approaches are required before we fully
understand the aetiology of the disuse or dormancy-associated
musculoskeletal phenotype.
Disuse-induced bone loss
Osteoporosis is a disorder of the skeleton characterised by decreased
bone mass and deterioration of the microarchitecture of bone tissue,
resulting in increased bone fragility and probability of fracture.
Osteopenia is less severe and refers to bone density that is below
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normal peak density but not low enough to be classified as
osteoporosis. Loss of bone due to chronic inactivity or decreased
mechanical demand (e.g. due to plaster cast immobilisation, bed rest
or hindlimb suspension) has been demonstrated in multiple
vertebrate species, including humans, monkeys, mice, rats,
turkeys, dogs and sheep (Gross and Rubin, 1995; Li et al., 2005a;
Lloyd et al., 2012; Rubin et al., 1988; Turner et al., 2006; Young
et al., 1983) (Table 1). Cast immobilisation for as little as 10 days
has been shown to result in osteopenia in rodents, as evidenced by
decreased dry bone mass, bone mineral density and metaphyseal
bone volume (Delling et al., 1970; Hott et al., 2003; Rantakokko
et al., 1999; Weinreb et al., 1989). Similarly, in turkeys, 8 weeks of
bone disuse resulted in a 12% loss in total bone area, which was
uniform along the diaphyseal shaft (Gross and Rubin, 1995).
Weight-bearing bones are particularly sensitive to the absence of
mechanical load, with the proximal femur and tibia exhibiting ∼5%
and 23% reductions in bone mineral density following 3 and
6 months of disuse, respectively (Watanabe et al., 2004; Young
et al., 1983). Consequently, the rigidity of bone, which is correlated
with bone mineral density, also declines during experimental
disuse.
Balancing formation and resorption: osteoblasts and osteoclasts
The mass of bone is regulated by the balance between the activity of
osteoblasts and osteoclasts (see Glossary), which form and resorb
bone, respectively. Skeletal unloading promoted by both cast
immobilisation and hindlimb suspension results in imbalanced rates
of bone turnover, leading to bone loss (Tuukkanen et al., 1991;
Uhthoff and Jaworski, 1978; Weinreb et al., 1989; Young et al.,
1986) (Table 1) and subsequent transient hypercalciuria (see
Glossary; Watanabe et al., 2004). Histomorphometric and
biochemical studies have demonstrated that immobilisation-
induced bone loss occurs predominantly because of an increase in
bone resorption associated with a decrease in bone formation (Bagi
and Miller, 1994; Rantakokko et al., 1999; Weinreb et al., 1989).
More recently, bone loss following 90 days of bed rest in humans
was shown to result from a dramatic elevation in bone resorption,
associated with only a mild increase in bone formation (Watanabe
et al., 2004). In hindlimb unloading experiments, where rodents are
suspended by their tails, bone formation is generally inhibited,
whereas bone resorption is enhanced or remains unchanged
(Apseloff et al., 1993; Bikle et al., 1994; Globus et al., 1986;
Moriishi et al., 2012; Simske et al., 1994; Vico et al., 1991; Wronski
and Morey, 1982). Interestingly, the susceptibility to bone loss due
to unloading is largely dependent on genetic background in mice,
with the common laboratory inbred mouse strain (C57BL/6)
consistently exhibiting markedly reduced bone formation and
enhanced bone resorption (Judex et al., 2004).
Osteocytes and sclerostin
The adaptive response of bone to variations in loading is controlled
by the capacity of resident bone cells to sense and translate
mechanical energy into a cascade of structural and biochemical
alterations within the cells, a process known asmechanotransduction.
Osteocytes (see Glossary), the most prevalent cells in mature bone,
are the primary cell type responsible for sensing mechanical load and
translating it into cell signalling and downstream bone remodelling
(Santos et al., 2009). Indeed, genetically modified mice lacking
osteocytes develop osteoporosis as a result of defective
mechanotransduction (Tatsumi et al., 2007). The canonical Wnt/β-
catenin signalling pathway plays a significant role inmodulating bone
Glossary
Aestivation
A summer or dry season form of dormancy. Desiccating conditions that
limit water and food availability typically trigger aestivation, often but not
always in conjunction with hot summer temperatures.
Dormancy
A state of transiently reduced metabolic activity.
Hibernation
A physiological state usually characterised by metabolic depression and
a decreased body temperature set point to conserve energy during
periods of low food availability and unfavourable environmental
conditions. Some temperate-zone hibernators, such as ground
squirrels, must intermittently arouse back to euthermia (i.e. proper
body temperature), a process referred to as interbout arousal (IBA).
Hypercalciuria
The excretion of unusually high levels of calcium in the urine.
Osteoblast
Cell from which bone develops; a bone-forming cell.
Osteoclast
Large multinucleated cell associated with the absorption and elimination
of bone.
Osteocyte
A mature osteoblast that has become embedded in the bone matrix.
Osteopenia
A reduction in the calcification or density of bone to a level that is below
normal peak density, but less severe than that resulting from
osteoporosis.
Osteoporosis
A decrease in the quantity of bone or atrophy of skeletal tissue.
Osteoporosis is a common age-related disorder characterised by
reduced bone mass and loss of normal skeletal microarchitecture and
strength, leading to increased risk of bone fracture.
Sarcopenia
Loss of skeletal muscle mass (atrophy) associated with ageing.
Satellite cell
Mononuclear, undifferentiated cell located in skeletal muscle fibre and
involved in skeletal muscle growth, repair and regeneration.
Tenotomy
Surgical cutting or division of a tendon.
Table 1. Animal models and experimental methods used to generate and study disuse-induced bone osteoporosis or osteopenia and associated
unbalanced bone remodelling
Disuse model Animal model Bone type References
Hindlimb suspension Mouse (Mus musculus) Tibia, femur Lloyd et al., 2012
Rat (Rattus norvegicus) Turner et al., 2006
Limb immobilisation (i.e. splint or plaster casting) Rat (Rattus norvegicus) Tibia, femur Hott et al., 2003
Dog (Canis familiaris) Metacarpal Li et al., 2005a
Bed rest/prolonged semi-recumbent position Human (Homo sapiens) Head, forearm, lumbar spine, femur Watanabe et al., 2004
Monkey (Macaca mulatta) Tibia Young et al., 1983
Tenectomy Sheep (Ovis aries) Calcaneus Rubin et al., 1988
Osteotomy Turkey (Meleagris gallopavo) Radius Gross and Rubin, 1995
Sciatic neurectomy Rat (Rattus norvegicus) Tibia Brighton et al., 1988
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mass through regulating processes including osteoblast
differentiation and function (MacDonald et al., 2009). Additionally,
the glycoprotein sclerostin (encoded by the SOST gene), which is
expressed in osteocytes, has been identified as a negative regulator of
bone growth that acts by inhibiting Wnt signalling and bone
formation (Li et al., 2005b) (Fig. 1). Sclerostin binds to low-density
lipoprotein receptor-related proteins 5 and 6 (LRP5/6) and, as a result,
inhibits osteoblast differentiation, activity and survival (Baron and
Rawadi, 2007). Several studies support the concept that osteocytes
possess mechanosensory functions, with sclerostin acting as a
primary signalling protein. Mice lacking a functional SOST gene
exhibit increased bone formation and strength (Li et al., 2008), and
loading of forearm bone is correlated with decreased SOST mRNA
and protein levels (Robling et al., 2008). These data were
complemented by experiments demonstrating that SOST gene
expression levels increase during tail suspension experiments
(Robling et al., 2008; Tatsumi et al., 2007). In addition, application
of an antibody against sclerostin was shown to inhibit disuse-induced
bone deterioration in mice, whereas serum levels of sclerostin were
markedly elevated during bed rest (for 90 days) in healthy human
males (Spatz et al., 2013, 2012). Such observations in both humans
and laboratory animals have resulted in the investigation of sclerostin
inhibition as a possible means of treating osteoporosis.
Extra-skeletal regulators of bone mass
Cell pathways involving molecules produced outside of the skeleton
are also involved in controlling bone mass and turnover. Bone
remodelling is regulated by rich innervation of the skeleton,
providing a source of various hormones, growth factors and
neurotransmitters that modulate various functions of bone. For
recent reviews on this topic, see Niedzwiedzki and Filipowska
(2015) and Quiros-Gonzalez and Yadav (2014). Important extra-
skeletal compounds that are relevant to this Review and which can
regulate bone remodelling include serotonin and the hormone
leptin. Although leptin is usually associated with controlling
appetite and body mass, studies have shown that it also negatively
regulates bone mass by inhibiting serotonin production and release
in a negative-feedback loop (Yadav et al., 2009).
Leptin may prevent excessive bone resorption by acting through
a neuropeptide known as cocaine- and amphetamine-regulated
transcript (CART). Elefteriou et al. (2005) found that CART reduces
the expression of receptor activator of nuclear factor kappa-B ligand
(RANKL), a key factor involved in osteoclast differentiation and
activation (Fig. 1). Furthermore, overexpression of peripheral CART
was shown to inhibit the development of osteoclasts and rescue the
low bone mass phenotype characteristic of CART-knockout mice
(Singh et al., 2008). Although we have only briefly touched on the
involvement of neuronal circuits in regulating bone, there are
multiple new molecular players implicated in the control of bone
mass that represent an active area of research, including brain-derived
neurotrophic factor (BDNF) and interleukin-1 (IL-1) (Quiros-
Gonzalez and Yadav, 2014). For example, BDNF and its receptors
are highly expressed in osteoblasts, and central BDNF deletion was
associated with increased whole-bone mineral density and bone
mineral content in mice (Quiros-Gonzalez and Yadav, 2014). In
contrast, administration of IL-1 to normal mice enhances bone
resorption and causes hypercalcaemia, while mice lacking IL-1
receptors exhibit a low bone mass phenotype (Sato et al., 1989).To
briefly summarise, immobilisation and unloading promote bone loss
secondary to an increase in resorption and decreased formation in
Osteocyte
Sclerostin
Sclerostin
antibody
CART
Osteoblast membrane
Cytoplasm
LRP5/6
β-Catenin
accumulation
Wnt target
genes
Bone formation
Wnt
Osteoclast
precursor
Mature
osteoclast
Active
osteoclast
Bone
resorption
RANK
(–)
(–)
RANKL
Fig. 1. Functions of canonical Wnt/β-catenin signalling, sclerostin and receptor activator of nuclear factor kappa-B ligand (RANKL) in bone
remodelling. The balance between bone formation and bone resorption is primarily modulated byWnt/β-catenin signalling (bone formation), sclerostin (negative
regulator of bone formation) and RANKL (osteoclast activation). Binding of Wnt proteins to low-density lipoprotein receptor-related proteins 5/6 (LRP5/6) on the
cell membrane of osteoblasts results in stabilisation of β-catenin and regulation of target genes that act to stimulate increased bone formation. Sclerostin, which is
secreted by osteocytes, may bind to LRP5/6 and inhibit Wnt signalling, thus preventing bone formation. RANKL present on the osteoblast membrane binds RANK
present on osteoclast precursors, and this promotes osteoclast maturation and resorption of bone. A neuropeptide called cocaine- and amphetamine-regulated
transcript (CART) can decrease the expression of RANKL.
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weight-bearing bones. Moreover, skeletal muscle atrophy often
occurs in parallel to bone loss and activity; muscle mass and strength
influence bone mass (Swift et al., 2010). However, because the
mechanisms that regulate mechanotransduction in bone and muscle
are complex, it is not entirely clear which specific mechanisms
operate in synergy during musculoskeletal disuse (Goodman et al.,
2015).
Disuse-induced muscle atrophy
Skeletal muscle is a highly plastic tissue; that is, it can change in
response to sustained stimuli. Like bone, the loss or ‘wasting’ of
skeletal muscle occurs during long periods of disuse (e.g. lack of
physical exercise, cast immobilisation, unloading or extended bed
rest) and has been reported in humans, mice, rats, guinea pigs, cats
and dogs (Bloomfield, 1997; Bodine, 2013a; Hudson and Franklin,
2002b) (Table 2). On a gross level, this manifests as a loss of whole-
muscle mass and reduced cross-sectional area of muscle fibres,
while at the subcellular level there is an overall loss of proteins,
cytoplasm andmitochondria. In this section, wewill introduce some
of the key mechanisms implicated in the progression of muscle
disuse atrophy (Fig. 2).
Regulators of skeletal muscle mass
The mass of skeletal muscle is determined by the difference in the
rates of protein degradation and protein synthesis. Muscle
hypertrophy is the result of an increase in protein synthesis and/or
a reduction in protein degradation, whereas muscle atrophy occurs
through a reduction in protein synthesis and/or an increase in the rate
of protein degradation. Several protein degradation pathways
contribute to the proteolysis of muscle proteins, including the
ubiquitin–proteasome system, Ca2+-dependent proteases (calpains),
the autophagy–lysosome system and caspases. Interactions among
these pathways appear to be critical in promoting proteolysis during
muscle disuse atrophy (Powers et al., 2011; Talbert et al., 2013),
while reactive oxygen species (ROS) have been implicated as a
primary trigger leading to proteolysis under disuse conditions
(Powers et al., 2011; Talbert et al., 2013). Gene expression profiling
of disused muscle has demonstrated both increases and decreases
in the expression of numerous genes over time, indicating that a
complex suite of biochemical changes occur simultaneously to
induce muscle atrophy (Chen et al., 2007; Stevenson et al., 2003). It
is beyond the scope of this Review to analyse all of the cellular
pathways implicated in the progression of muscle disuse atrophy in
depth, so readers are directed to several recent reviews on the topic
(Bodine, 2013a; Brooks and Myburgh, 2014; Powers et al., 2011;
Schiaffino et al., 2013). In the remainder of this section, we focus on
summarising how protein synthesis is affected during muscle disuse
atrophy, specifically discussing IGF1–Akt–mTOR signalling and
myostatin, as well as the importance of myonuclear apoptosis.
The role of mTOR in muscle remodelling
The retention of muscle mass andmyofibre hypertrophy are, to some
extent, regulated by insulin-like growth factor-1 (IGF1) signalling, as
IGF1 can stimulate muscle growth via phosphatidylinositol
3-kinase–Akt signalling (PI3K/Akt) (Rommel et al., 2001). Active
Akt has many significant downstream actions; for example, it
modulates the phosphorylation of mTOR (mammalian target of
rapamycin), a protein kinase that mediates various processes
involved in cell proliferation and growth, including protein
synthesis (Goodman, 2014). Extensive human and rodent studies
have revealed the role of mTOR in the modulation of skeletal muscle
mass and protein synthesis in response to different mechanical
stimuli (Goodman, 2014). Direct activation of Akt is associated with
skeletal muscle hypertrophy, and has also been shown to preserve
muscle fibre size in skeletal muscles undergoing atrophy (Bodine
et al., 2001). A decrease in the levels of native and phosphorylated
Akt is evident during the atrophy accompanying hindlimb
unloading, and theoretically this could promote reduced mTOR
activity and a subsequent reduction in protein synthesis (Bodine
et al., 2001). P70S6 kinase and the eukaryotic initiation factor 4E
(eIF4E)-binding protein (4E-BP1) are two other important proteins
that can be regulated through phosphorylation by mTOR. For
example, P70S6 kinase is activated upon phosphorylation,
promoting the formation of protein translation initiation
complexes. Data indicate that P70S6 kinase and 4E-BP1 are
involved in the decreased translation rate observed during disuse
atrophy (Jackman and Kandarian, 2004). Curiously, a
counterintuitive upregulation of mTOR has been reported during
muscle inactivity induced by denervation, which might be due to
increased amino acid influx from protein degradation pathways, such
as the ubiquitin–proteasome system (Quy et al., 2013). Thus,
although the precise role of mTOR-related signalling throughout
different systems of muscle atrophy remains contentious, mTOR is
still considered to be very important in modulating many cellular
processes during muscle remodelling (Goodman, 2014).
Myostatin negatively regulates muscle growth
Another signalling pathway that controls skeletal muscle growth
involves myostatin, a protein that acts as a negative regulator of
muscle growth and size in adult mammals (Elliott et al., 2012).
Blocking the myostatin pathway using various techniques has been
shown to lead to muscle hyperplasia and hypertrophy (Zhu et al.,
2000). Myostatin is suspected to play a role in muscle atrophy
during disuse, with some studies demonstrating elevated abundance
Table 2. Animalmodels and experimental methods used to generate and study disuse-induced skeletalmuscle atrophy and associated unbalanced
protein turnover
Disuse model Animal model Bone type References
Hindlimb suspension Rat (Rattus norvegicus) Plantar flexors Swift et al., 2010
Mouse (Mus musculus) Soleus Ferreira et al., 2008
Limb immobilisation (i.e. joint immobilisation
or plaster casting)
Cat (Felis catus) Tibialis posterior Nordstrom et al., 1995
Dog (Canis familiaris) Rectus femoris, vastus lateralis,
vastus medialis
Lieber et al., 1988
Guinea pig (Cavia porcellus) Soleus, gastrocnemius Maier et al., 1976
Human (Homo sapiens) Gastrocnemius Chen et al., 2007
Bed rest Human (Homo sapiens) Vastus lateralis Brocca et al., 2012
Detraining Human (Homo sapiens) Quadriceps Andersen et al., 2005
Denervation Mouse (Mus musculus) Extensor digitorum longus Stockholm et al., 2001
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of myostatin mRNA and protein in disused muscles (Reardon et al.,
2001; Wehling et al., 2000). In addition, experimental inhibition of
myostatin in mouse skeletal muscles unloaded for 14 days
significantly decreases the extent of muscle atrophy (Murphy
et al., 2011). Myostatin signalling can activateMAFbx (also known
as atrogin-1) and MuRF1, two genes consistently upregulated in
different muscle atrophy models (Elliott et al., 2012). In mammalian
myoblasts, myostatin stimulates withdrawal from the cell cycle and
promotes a quiescent state rather than differentiation or apoptosis
(Brooks and Myburgh, 2014). This is achieved by inhibiting the
activity of MyoD, which plays a fundamental role in regulating
muscle differentiation (Elliott et al., 2012). Additionally, myostatin
inhibits activation of the Akt/mTOR protein synthesis pathway
(Trendelenburg et al., 2009); therefore, decreased myostatin gene
expression may facilitate mTOR signalling by way of reducing this
inhibition.
Apoptotic processes during muscle disuse atrophy
Like osteoclasts, myofibres are multinucleated cell types. This
feature of skeletal muscle has led to the concept of the myonuclear
domain theory, which describes the theoretical amount of cytoplasm
within a myofibre that can be regulated by a single myonucleus
(Fig. 3). Under conditions of muscle growth, hypertrophy or
overload, there is an increase in myonuclear number as the muscle
fibre increases in size (van der Meer et al., 2011). The responses of
both myonuclear number and domain size with muscle atrophy are
less well understood, although loss of myonuclei from existing
fibres has been reported during skeletal muscle disuse (Allen et al.,
Myofibre membrane
Cytoplasm
IGF-1
PI3K
Akt
mTOR
Protein synthesis
Muscle growth Muscle atrophy
Myogenic genes
Myostatin
MAFbx
MuRF1
Protein degradation
(proteasome, autophagy,
caspase-3, calpain)
Myonuclear apoptosis
Release of
pro-apoptotic factors
ROS
Fig. 2. Signalling pathways associated with muscle growth and muscle disuse atrophy. Insulin-like growth factor-1 (IGF-1) stimulates muscle growth via
phosphatidylinositol 3-kinase–Akt signalling (PI3K/Akt). Active Akt has many significant downstream actions, including modulating the phosphorylation of
mammalian target of rapamycin (mTOR), a protein kinase that regulates processes including cell proliferation, protein synthesis and muscle growth. Myostatin, a
well-known negative regulator of muscle growth and size, is able to repress the PI3K/Akt/mTOR pathway. Binding of myostatin to its receptor also blocks the
transcription of genes responsible for myogenesis, and can activate MAFbx (also known as atrogin-1) and MuRF1, two key proteolytic genes consistently
upregulated in different muscle atrophy models. Skeletal muscle atrophy can be induced by mitochondrial production of reactive oxygen species (ROS), which
stimulates protein degradation via a number of key pathways, including the ubiquitin–proteasome system, autophagy, calpains and caspase-3. Mitochondrial
ROS production can also induce permeabilisation of the mitochondrial membrane, resulting in the release of pro-apoptotic factors, including cytochrome c and
apoptosis-inducing factor. The release of cytochrome c can subsequently activate caspase-3, which may promote myonuclear apoptosis. Dashed lines and
arrows represent the existence of intermediate steps, which have been omitted from the figure for simplicity.
Atrophy Hypertrophy
  Loss of myonuclei (apoptosis)
  Myofibre CSA ↓
  Myofibrillar proteins ↓
  Addition of myonuclei
  Myofibre CSA ↑
  Myofibrillar proteins ↑
Fig. 3. Myonuclear gain and loss during skeletal muscle hypertrophy and atrophy. As myofibres grow in response to hypertrophic stimuli, myonuclei
are recruited to support an increase in the volume of the cytosol. It has been suggested that, under atrophic conditions, nuclei are eliminated from the symplasm
by myonuclear apoptosis (red crosses). During hypertrophy or disuse atrophy, alterations in the number of myonuclei coincide with changes in myoﬁbrillar
protein content and myoﬁbre cross-sectional area (CSA). This results in a constant ratio of cytoplasmic area to nuclear number, i.e. constant size of the
myonuclear domains (depicted in the figure by dashed white lines). Note that apoptosis as a mechanism for myonuclear loss during muscle disuse atrophy is
controversial.
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1997; Gallegly et al., 2004; Smith et al., 2000). This may be due to
apoptotic-like processes (Fig. 3). The defining features of apoptosis
are consistent in most cell types (e.g. cell membrane blebbing, DNA
fragmentation, phosphatidylserine externalisation), and cultured
myocytes exhibit such hallmark morphological and biochemical
characteristics in response to apoptotic stimuli (Adhihetty and
Hood, 2003). As skeletal muscle is multinucleated, the likelihood of
extensive myofibre death is relatively low, whereas individual
myonuclear loss is probably a more common event within muscle
tissue, ultimately leading to cellular remodelling.
Rats experiencing 2 weeks of hindlimb suspension exhibit an
increase in the number of morphologically abnormal myonuclei
and myonuclei showing double-stranded DNA fragmentation (as
quantified using the TUNEL assay) (Allen et al., 1997) (Table 3).
During similar prolonged periods of skeletal muscle disuse, rats
also exhibit a reduction in myonuclear number and domain size, a
decrease in the activity of satellite cells (see Glossary) in muscle
fibres, and increases in several molecular markers of apoptosis,
including elevated expression of Bax and Bcl-2 protein, increased
mitochondrial cytochrome c content in the cytosol and nuclear
colocalisation of EndoG (an apoptotic effector) in myonuclei
(Dupont-Versteegden et al., 2006; Leeuwenburgh et al., 2005; Siu
et al., 2005; Wang et al., 2006) (Table 3). Maximal caspase-3 and
apoptosis-inducing factor expression was found in the soleus
muscle of mice after 12 and 24 h of hindlimb suspension,
respectively, which coincided with the highest levels of apoptotic
DNA fragmentation (Ferreira et al., 2008). Further evidence that
apoptosis is involved in the progression of muscle disuse atrophy
arises from unilateral limb immobilisation studies in rats, mice and
rabbits (Smith et al., 2000; Vazeille et al., 2008; Zhu et al., 2013),
and a bird muscle loading/unloading model (Alway et al., 2003)
(Table 3).
However, apoptosis as a mechanism for causing myonuclear loss
during muscle atrophy is highly controversial, as recent studies
using in vivo time-lapse imaging found that the number of
myonuclei remained relatively constant during both tenotomy (see
Glossary) and detraining (Gundersen, 2016). Whereas in vivo
imaging allows direct examination of myonuclei, many studies have
reported markers for apoptosis in homogenates derived from
atrophying muscle and have interpreted this as apoptosis of
myonuclei, but these findings could reflect apoptosis of nuclei
from other cell types, such as stromal cells or satellite cells
(Gundersen, 2016). Indeed, a recent study found that although the
amount of Bax mRNA and the number of TUNEL-positive nuclei
were significantly increased in immobilised human muscle, this was
mainly localised in the interstitial space between myocytes, thus
potentially being attributable to other cell types (Suetta et al., 2012).
Nonetheless, a decrease in myonuclei has been observed during
Table 3. Morphological and molecular responses implicating apoptosis during muscle disuse atrophy in conventional experimental models
Disuse model Species Muscle Summary References
Hindlimb suspension
(14 days)
Rat (Rattus norvegicus) Soleus TUNEL-positive staining in
myonuclei ↑
Allen et al., 1997
Soleus Apoptotic DNA fragmentation ↑ Leeuwenburgh et al., 2005
Gastrocnemius Bax and Bcl-2 protein ↑
Mitochondrial cytochrome c
release ↑
Siu et al., 2005
Hindlimb suspension
(16 days)
Soleus Satellite cell activity ↓
Myonuclear number ↓
Myonuclear domain size ↓
Wang et al., 2006
Hindlimb suspension
(7 days)
Soleus TUNEL-positive staining in
myonuclei ↑
EndoG-positive staining in
myonuclei ↑
Dupont-Versteegden et al.,
2006
Hindlimb casting (8 days) Gastrocnemius TUNEL-positive staining in
myonuclei ↑
Caspase-3 activity ↑
xIAP protein* ↓
Vazeille et al., 2008
Hindlimb suspension
(48 h)
Mouse (Mus musculus) Soleus Caspase-3 activity ↑
Apoptosis-inducing factor
expression ↑
Apoptotic DNA fragmentation ↑
Ferreira et al., 2008
Hindlimb casting (14 days) Soleus TUNEL-positive staining in
myonuclei ↑
Zhu et al., 2013
Gastrocnemius Caspase-3 protein ↑
Hindlimb casting (6 days) Rabbit (Oryctolagus
cuniculus)
Soleus TUNEL-positive staining in
myonuclei ↑
Presence of condensed chromatin
Presence of irregularly shaped
myonuclei
Smith et al., 2000
Wing unloading Quail (Coturnix coturnix) Patagialis Presence of PARP‡-positive
nuclei
Caspase-3, -7, -8, -10§ activity ↑
Alway et al., 2003
Leg cast immobilisation
(4 days)
Human (Homo sapiens) Vastus lateralis TUNEL-positive staining in
myonuclei ↑¶
Bax mRNA ↑
Suetta et al., 2012
*xIAP (aka BIRC4) protein prevents apoptotic cell death; ‡poly(ADP-ribose) polymerase (PARP) can induce cell death by stimulating mitochondria to release
apoptosis-inducing factor; §caspases-3 and -7 execute apoptosis whereas caspases-8 and -10 are involved in initiating apoptosis; ¶restricted to the interstitial
space between myocytes.
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other atrophy-inducing conditions, such as spinal cord isolation and
transection, microgravity, sarcopenia (see Glossary) and
neuromuscular pathologies (Brooks and Myburgh, 2014). Thus,
elimination of myonuclei by nuclear apoptosis remains a rational
concept to explain the regularity of myonuclear domain size
regardless of atrophy (Brooks and Myburgh, 2014).
Dormant animals as model systems
There are a plethora of molecular mechanisms implicated in the
events leading to musculoskeletal loss, and the deterioration of these
tissues due to prolonged disuse appears to affect most vertebrates
studied thus far. Not surprisingly, this includes a relatively limited
variety of mammalian model systems (typically rodents and
humans) which have been artificially immobilised in a laboratory
or clinical setting. Some of the deleterious effects of
musculoskeletal disuse may be reversed upon the return of normal
weight bearing of the limbs, but this can depend on factors such as
age, the duration and/or method of immobilisation and the type of
bone or muscle (Jaworski and Uhthoff, 1986). Currently, there are
limited therapeutic options for the treatment of osteoporosis and
muscle disuse atrophy, because of an incomplete understanding of
the cellular and molecular mechanisms involved in the induction
and maintenance of these conditions. Understanding the physiology
of animals that undergo natural periods of disuse but suffer
negligible musculoskeletal deterioration could not only reveal novel
regulatory factors but also lead to new therapeutic options.
Maintenance of musculoskeletal properties in hibernators and
aestivators
It is well known that minimal loss of musculoskeletal mass and
function occurs in hibernating mammals, despite the fact that they
experience suppressed neural activity and natural periods of
prolonged musculoskeletal disuse (Bodine, 2013b; Cotton, 2016;
McGee-Lawrence et al., 2008). This applies to many species, such
as bears, squirrels, woodchucks, bats, hamsters, prairie dogs and
marmots (Cotton, 2016; Cotton and Harlow, 2010; Doherty et al.,
2012; James et al., 2011; McGee-Lawrence et al., 2015, 2008; Utz
et al., 2009; Wojda et al., 2012). However, some small
hibernators, such as the 13-lined ground squirrel (Ictidomys
tridecemlineatus) have been reported to exhibit microstructural
bone loss (osteocytic osteolysis) during hibernation bouts, which
has not been observed in larger hibernating animals (McGee-
Lawrence et al., 2011).
Although hibernating mammals have been widely used as
‘natural analogues’ to which clinical disuse models such as bed
rest or cast immobilisation may be compared, vertebrates that
undergo aestivation also experience extended bone and muscle
disuse during bouts of dormancy. This includes aestivating frogs,
fish and reptiles. Several species of arid-zone frogs (e.g. Cyclorana
alboguttata, Lepidobatrachus laevis, Neobatrachus aquilonius)
survive long-lasting droughts by excavating an underground
burrow, constructing a waterproof cocoon of shed skin and
mucus, and conserving energy by entering aestivation (Flanigan
and Guppy, 1997; Withers, 1995). In this capacity, these frogs are
quiescent and immobile in their burrows, often for many months if
not years. Consequently, the green-striped burrowing frog
(C. alboguttata) has recently been used in our laboratory to study
the effects of aestivation on skeletal muscle and bone, and the
associated physiological and molecular processes that may confer
resistance to musculoskeletal deterioration (Hudson et al., 2004,
2006; Hudson and Franklin, 2002a; Mantle et al., 2009; Reilly et al.,
2013; Symonds et al., 2007; Young et al., 2013). Prolonged
inactivity associated with aestivation has been shown to have
negligible effects on muscle mass, whole-muscle cross-sectional
area, myofibre number, in vitro force production, bone-bending
strength and swimming performance in C. alboguttata (Hudson
et al., 2004, 2006; Hudson and Franklin, 2002a; Mantle et al.,
2009). The apparent absence of musculoskeletal losses in
Cyclorana is consistent with the patterns reported for periods of
disuse in hibernators as discussed above, and it is evident that the
responses of muscle and bone to disuse in disparate organisms that
undergo dormancy are profoundly different from those of typical
models of disuse.
Hibernation and aestivation are usually characterised by
metabolic depression to preserve energy stores during prolonged
fasting (Carey et al., 2003; Guppy andWithers, 1999). For example,
metabolic rate is decreased to ∼5% of euthermic levels in
hibernating Alpine marmots (Heldmaier et al., 2004), and to 20–
30% of the normal resting rate in aestivating frogs (Kayes et al.,
2009; Withers, 1993). As musculoskeletal remodelling is associated
with a high metabolic cost, increased rates of remodelling (which
often occur with disuse) during dormancy would compete for
energy reserves with essential physiological processes, such as
cardiorespiratory function. However, increased expression of
selected genes and proteins in different cellular pathways has been
reported during metabolic depression, suggesting that remodelling
does occur in certain organs and tissues (Storey and Storey, 2010).
For aestivating or hibernating animals, any degenerative changes to
muscle and bone would be disadvantageous during the transition
from a dormant to an active state. This is particularly true for
aestivating frogs that only have a narrow window of opportunity to
feed and breed when the summer rains arrive and before the highly
ephemeral waters retreat.
Despite a number of hypotheses proposed in the literature as to
how muscle and bone deterioration is inhibited during dormancy
(Harlow et al., 2001; Tinker et al., 1998; Wickler et al., 1991), a
major hindrance to a complete understanding of the phenomenon is
the lack of knowledge of the cellular and molecular pathways that
are vital for musculoskeletal sparing, and whether any of these are
universal across different forms of dormancy. Recent studies have
begun to pinpoint important differences between the responses of
hibernating and aestivating animals and typical animal models to
immobilisation and inactivity. The following sections will discuss
several recent exciting studies that examine physiological,
molecular and cellular strategies predicted to be paramount in
conserving musculoskeletal integrity during dormancy.
Mechanisms underpinning the inhibition of osteoporosis
The black bear (Ursus americanus) has been used to study bone
remodelling, as these animals are routinely inactive for up to
6 months during hibernation without suffering losses in trabecular
or cortical bone mass (McGee-Lawrence et al., 2015). It has been
hypothesised that rates of bone resorption and formation remain
stable in hibernating Ursus to help prevent calcium imbalance
(Donahue et al., 2006). However, previous investigations using
serum and histological markers of bone remodelling to investigate
this idea provided inconsistent data (Donahue et al., 2006; McGee
et al., 2008; Seger et al., 2011), possibly as a result of the effect of
decreased renal function on serum markers. A more recent study
using more reliable markers of bone turnover [bone-specific
alkaline phosphatase (BSALP) and tartrate-resistant acid
phosphatase (TRACP)] provided strong evidence that bone
resorption and formation are suppressed during hibernation in
black bears, in contrast to non-hibernating animals undergoing
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disuse (Fig. 4). These data are supported by histomorphometric
measurements (osteoid surface, eroded surface, ratio of osteoid to
eroded surface) of trabecular bone in grizzly bears, which exhibited
no change between active and hibernating states (McGee-Lawrence
et al., 2009; McGee et al., 2008). The maintenance of balanced bone
formation and resorption during hibernation is consistent with the
ability of hibernators to retain calcium homeostasis and, thus,
cellular function.
Early studies on ground squirrels, golden hamsters and little
brown bats provided evidence that, unlike bears, these species
undergo bone loss as a consequence of reduced osteoblastic
formation and increased bone resorption during hibernation
(McGee-Lawrence et al., 2008). Although these studies lacked
thorough quantification of a wide array of bone properties, for small
mammalian hibernators there is still conflicting evidence as to
whether bone loss regularly occurs during dormancy. Whereas
both arctic and golden-mantled ground squirrels retain cortical
bone properties and strength following hibernation (Utz et al.,
2009; Wojda et al., 2012), data indicate that hibernating
I. tridecemlineatus might be unable to avoid microstructural
losses of cortical and trabecular bone (McGee-Lawrence et al.,
2011). Nevertheless, because bone geometrical and mechanical
properties do not differ significantly between hibernating and active
squirrels, these animals can still perhaps activate the appropriate
physiological mechanisms to maintain bone macrostructure and
strength throughout hibernation in preparation for normal skeletal
function during arousal.
What are the specific mechanisms by which hibernators might
largely preserve skeletal function during prolonged inactivity?
Despite the knowledge that sclerostin plays an important role in
bone mechanotransduction in the majority of mammals, very little is
known about sclerostin and related pathways during dormancy.
Seger et al. (2011) measured serum sclerostin levels in both
hibernating and non-hibernating black bears, and found that there
was no significant difference between the two groups. However, a
subset of hibernating bears did show increased levels of serum
sclerostin, which is a skeletal signal of unloading. Whether these
findings translate to a physiological effect in the bone of hibernating
bears is unclear.
As previously mentioned, leptin plays a critical role in energy
metabolism by modulating appetite and body mass, but it is also an
important effector of sympathetic input into bone through its
interactions with brain-derived serotonin. Thus, leptin could
contribute to the control of balanced bone remodelling during
hibernation and aestivation. In hibernators, serum leptin usually
peaks during the autumn as a result of increased food intake in
preparation for dormancy (Doherty et al., 2014). Elevated
concentrations of leptin during pre-hibernation and early
hibernation have been documented in species such as bears,
woodchucks, marmots and ground squirrels (see Doherty et al.,
2014, and references therein), before the level of leptin gradually
drops well into the hibernation season. It has been suggested that
suppressed bone resorption in hibernating black bears may be due to
leptin-mediated stimulation of hypothalamic CART (Seger et al.,
2011). Interestingly, McGee-Lawrence et al. (2015) recently
reported a >1000% increase in serum CART levels in hibernating
bears compared with pre-hibernation animals, which corroborates
the idea that CART may have a potent inhibitory effect on bone
resorption throughout dormancy.
At the molecular level, gene expression data from the bone of
bears has shown that the transcription of genes involved in anabolic
processes of tissue formation (such as cartilage development and
osteogenesis) increases during hibernation (Fedorov et al., 2012).
Although the expression of genes with known roles in bone
resorption was found to be unchanged, Fedorov et al. (2012)
reported significant downregulation of genes involved in the
stimulation of osteoclast differentiation; it was suggested that this
might counteract the increased osteoclastogenesis and bone
resorption typically seen in disuse scenarios.
Unfortunately, small- and medium-sized hibernators as well as
non-mammalian vertebrates that experience dormancy (aestivating
frogs and hibernating snakes, etc.), are extremely understudied
with regard to the physiological and molecular mechanisms
underpinning the retention of bone properties despite disuse.
There are many neural, endocrine, paracrine and mechanical signals
that can influence bone mass and strength, and the studies outlined
above do offer novel insights into the bone remodelling processes
that hibernating bears use to avoid the negative consequences of
prolonged disuse. An intriguing question is whether other dormant
animals with different strategies of metabolic depression (e.g.
hibernating squirrels or bats, and aestivators) demonstrate similar
alterations in sclerostin, leptin or CART during dormancy.
Mechanisms underpinning inhibition of muscle disuse atrophy
Examinations of skeletal muscle changes (or lack thereof ) in
mammalian hibernators have largely focused on rodents, bears and
bats, with fewer studies investigating skeletal muscle changes in
aestivating amphibians (Cotton, 2016; Hudson and Franklin,
2002b; Y. Maistrovski, Regulation of anti-apoptotic pathways in
skeletal muscle and liver of an estivating species, Xenopus laevis,
MSc thesis, Carleton University, Ontario, Canada, 2011). The
morphological changes and remodelling of contractile performance
that occur in the muscle of hibernating mammals and aestivating
frogs have recently been extensively reviewed elsewhere (Cotton,
2016; James, 2010). Studies on muscle types from small hibernators
such as hamsters, ground squirrels and bats have shown relatively
small changes in both muscle mass and protein content during
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Fig. 4. The concentration of bone-specific alkaline phosphatase (BSALP),
a marker of bone formation, measured in sera of black bears (Ursus
americanus) over one full hibernation season. Dashed lines signify the
approximate start and finish times of hibernation (January to March). Levels of
serum BSALP were lowest between January and March, demonstrating that
hibernating bears have suppressed bone turnover relative to that of active
animals (McGee-Lawrence et al., 2015). Reproduced with permission from
Journal of Experimental Biology.
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hibernation, with most reporting up to only 15% and 30% decreases
in mass and protein, respectively (Cotton, 2016). Alterations in
muscle protein content from hibernating bears have been shown to
be similar to those of small mammalian hibernators, with an average
decrease in muscle protein content of 5–10% (Cotton, 2016). In
C. alboguttata, 6–9 months of aestivation was reported to have no
effect on muscle mass, water content or myofibre number in
gastrocnemius or cruralis muscles (Mantle et al., 2009). Similarly,
6 months of aestivation had no effect on the total cross-sectional
area of cruralis muscle (Hudson et al., 2006; Mantle et al., 2009).
Furthermore, aestivation for 9 months in this species had no effect
on myofibre cross-sectional area in the gastrocnemius, a key muscle
involved in power output during locomotion (Mantle et al., 2009).
Unlike C. alboguttata, just 2 weeks of hindlimb immobilisation in
more typical laboratory models, such as rats, can promote a 32%
reduction in gastrocnemius myofibre cross-sectional area
(Sakakima et al., 2004).
Given the overall maintenance of muscle morphological
parameters during hibernation and aestivation, it is not surprising
that there are also limited changes in muscle mechanics during
simulated sprint or endurance-type activities (Cotton, 2016; James,
2010). Below, we discuss several recent studies on multiple species
that have addressed the physiological and cellular mechanisms by
which dormant animals might resist muscle disuse atrophy and
maintain muscle performance.
Regulation of protein synthesis
Under typical conditions, muscle homeostasis is accomplished by
balancing the continuous processes of protein degradation and
synthesis, which are controlled by mechanisms incorporating
multiple signals including energy availability and mechanical
loading. Rates of both protein degradation and synthesis can be
reduced by up to 70% in the skeletal muscle of hibernating bears
(Lohuis et al., 2007). However, more recent studies found increased
expression of mRNAs largely involved in protein biosynthesis and
ribosome biogenesis in the muscles of both hibernating bears and
arctic ground squirrels relative to those of summer active animals,
suggesting that induction of translation could be enhanced at
different stages of hibernation (Fedorov et al., 2014, 2009). Despite
the need for global suppression of energetically expensive processes
such as transcription and translation during dormancy (Storey and
Storey, 2010), a number of recent studies have emphasised the
importance of maintaining protein synthesis in hibernating muscle
through activation of the mTOR signalling cascade (Andres-Mateos
et al., 2013; Fedorov et al., 2014; Lee et al., 2010; Nowell et al.,
2011). For example, hibernating I. tridecemlineatus were recently
shown to exhibit increased expression of genes in the IGF1–Akt–
mTOR signalling pathway (igf1, igf2, akt1, mTOR and rps6kb1),
which is associated with the hypertrophic response to increased
mechanical loading and is a key pathway promoting protein
synthesis (Vermillion et al., 2015). Interestingly, genes encoding
IGF-binding proteins, which have known functions in inhibiting
protein synthesis, have also been reported to be strongly suppressed
in the skeletal muscle of hibernating squirrels and aestivating frogs
(Reilly et al., 2013; Vermillion et al., 2015).
Furthermore, although bats have been found to show depressed
rates of protein turnover during torpor, periodic arousals in both bats
and squirrels seem to be associated with fluctuations in the
activation of mTOR (Lee et al., 2010; Wu and Storey, 2012; Yacoe,
1983). Like mTOR, p70S6 kinase and 4E-BP1 are downstream
targets of Akt and are thus key regulatory proteins involved in
translation and protein synthesis. The levels of the phosphorylated
forms of these proteins increase significantly during hibernation in
I. tridecemlineatus, which is a strong indicator of activation of
mTOR-mediated protein synthesis (Andres-Mateos et al., 2013).
The same study showed that increased mTOR activity appears to be
controlled by the serum and glucocorticoid-inducible kinase 1
(SGK-1), a previously unknown mediator of skeletal muscle
homeostasis and function.
Very recent evidence for increased protein synthesis during
hibernation comes from a study that used MRI to measure hindlimb
muscle volume, and the relatively novel non-isotopic SUnSET
technique to quantify skeletal muscle protein synthesis in ground
squirrels (Hindle et al., 2015). It was shown that during early
hibernation (October), ground squirrels experienced a 66% decline
in protein synthesis compared with fasted animals in the summer.
Remarkably, protein synthesis increased significantly as late winter
approached and then returned to summer baseline levels, providing
strong evidence for regrowth of skeletal muscles during hibernation.
Therefore, although increasing protein synthesis is at odds with the
need to conserve energy during metabolic depression, a substantial
body of evidence suggests that increasing protein synthesis could be
necessary at specific time points during dormancy.
Because of its involvement in the regulation of muscle mass,
myostatin has been investigated in animals that undergo metabolic
depression. Myostatin protein levels in mixed hindlimb muscle of I.
tridecemlineatus were found to be largely constant throughout
torpor relative to those of controls, but increased significantly
during arousal (Brooks et al., 2011). In another study on hibernating
squirrels, a significant reduction in myostatin gene expression was
found in soleus and diaphragm muscles, which are both resistant to
atrophy in this species (Nowell et al., 2011). Other studies have
shown reduced levels of myostatin mRNA during hibernation and
aestivation, which could be associated with enhanced protein
synthesis by facilitating mTOR signalling (Reilly et al., 2013;
Vermillion et al., 2015).
Regulation of apoptosis
Apoptotic pathways balance signals which either promote or
prevent cell death (i.e. pro-apoptotic and anti-apoptotic pathways,
respectively). Changes in apoptotic proteins might be expected to
occur during hibernation and aestivation in order to preserve cells
under conditions that are highly detrimental to most animals (e.g.
alterations in temperature, deprivation of nutrients, ischaemia and
prolonged muscle inactivity). There is evidence that upregulation of
anti-apoptotic mechanisms might be important in maintaining
skeletal muscle in aestivating vertebrates (Table 4).
For example, although the African clawed frog (Xenopus laevis)
is almost exclusively aquatic, this species may enter aestivation
during dry periods when water becomes scarce and migration
becomes impossible. The transcription factor STAT5, which targets
genes that include those with cell survival and proliferation
functions, appears to be activated in response to dehydration
stress in the skeletal muscle of Xenopus, where it probably promotes
increased transcription of multiple anti-apoptotic genes and/or
proteins (Y. Maistrovski, Regulation of anti-apoptotic pathways in
skeletal muscle and liver of an estivating species, Xenopus laevis,
MSc thesis, Carleton University, Ontario, Canada, 2011) (Table 4).
A gene expression profiling study of muscle from aestivating
C. alboguttata found a coordinated upregulation of genes associated
with cell death and survival and DNA replication, recombination
and repair (Reilly et al., 2013) (Table 4). The increased expression
of a number of pro-apoptotic genes in muscle from aestivating frogs
may serve to eliminate individual myocytes (and intracellular
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macromolecules) that are defective, damaged or otherwise pose a
potential threat to the integrity of the animal. Indeed, data from
aestivating lungfish indicate increased cellular turnover in skeletal
muscle tissue due to activation of apoptotic pathways (Amelio et al.,
2013) (Table 4). However, in response to potential apoptotic
signals, cells would need to avoid triggering premature or excessive
apoptosis, which can be accomplished by balancing the ratio of
pro- and anti-apoptotic mechanisms. Accordingly, aestivating
burrowing frogs exhibited enhanced expression of genes with
reported anti-apoptotic functions [e.g. the inhibitor of apoptosis
protein (IAP), also known as survivin or BIRC5; Reilly et al., 2013].
Similar to aestivating frogs, studies of differential gene expression
in arctic ground squirrels (Spermophilus parryii) found that the
mRNA expression of genes involved in apoptosis increased
significantly in skeletal muscle during interbout arousals (Yan
et al., 2008). In skeletal muscle of ground squirrels, however, the
protein expression of xIAP (aka BIRC4) increased significantly in
torpid animals (Rouble et al., 2013) (Table 4). This indicates the
possibility that IAP-mediated inhibition of caspase activity may be a
critical regulatory mechanism which enhances survival of myocytes
in dormant species that are resistant to disuse atrophy. These
molecular studies are supported at a morphological level, as muscles
from hibernating edible dormice exhibit no evidence of necrosis and
very few apoptotic myonuclei (Malatesta et al., 2009).
Conclusions and future directions
In this Review we have summarised some of the recent studies that
have advanced our knowledge regarding the strategies that might be
used by dormant animals to preserve musculoskeletal integrity. By
examining the differences and similarities in musculoskeletal
biology between different species that undergo distinct forms of
dormancy, it is hoped that this Review will promote new insights
and ideas for future research.
Global gene expression profiling studies have greatly advanced
our knowledge regarding the transcriptional changes that occur
in bone and muscle during hibernation and aestivation. These
analyses provide an array of candidate genes for future gene or
protein expression studies in bone and muscle of dormant
animals. The interpretation of the gene expression data is based
on the assumption that observed mRNA levels correlate with
protein abundance and carry over to a phenotypic response.
However, it is probably true that muscle or bone mRNA and
protein abundance are not always highly correlated, as a result of
regulation at different levels (e.g. post-transcriptional or
post-translational regulation). For example, although expression
of the birc5 gene (survivin) was reported to be significantly
increased in muscle during aestivation in C. alboguttata, it is
known that survivin expression is regulated by a number of
distinct post-transcriptional mechanisms (Zhang et al., 2006).
High-throughput or ‘omics’ methods, such as proteomic and
metabolomic measurements, can provide a more comprehensive
assessment of the subcellular changes that may occur in
musculoskeletal tissues of hibernators and aestivators,
particularly at distinct time points, and how these changes relate
to musculoskeletal sparing. Indeed, there were no proteomic
signatures of skeletal muscle atrophy (e.g. protein turnover)
detected in skeletal muscle of I. tridecemlineatus throughout
different phases of hibernation (Hindle et al., 2011).
Despite the scale and novelty of information generated using
genomics and proteomics techniques, hypothesis-driven studies that
test predictions at the whole-animal, tissue, cellular and molecular
level will continue to be critical for future investigations of
the mechanisms of musculoskeletal sparing during dormancy.
For example, while pro- and anti-apoptotic molecules vary in
expression and/or abundance in dormant muscle, are there losses in
the number of myonuclei during dormancy or does the number of
myonuclei not differ from that of active animals?
In future investigations, it would be informative to examine the
effect of experimental immobilisation on the skeletal muscles of
both non-dormant (i.e. awake, aroused, summer euthermic) and
dormant animals of the same species. If dormancy is an important
factor in protecting animals against disuse-associated muscle and
Table 4. Apoptotic pathways implicated in skeletal muscle remodelling during dormancy
Species Summary Signalling References
Hibernation Arctic ground squirrel (Spermophilus parryii) bcl-2 expression ↑, arousal bouts
birc2 expression ↑, arousal bouts
bid expression ↑, arousal bouts
tp53 expression ↓
Anti-apoptotic
Anti-apoptotic
Pro-apoptotic
Pro-apoptotic
Yan et al., 2008
Thirteen-lined ground squirrel (Ictidomys
tridecemlineatus)
Mitochondrial-associated pro-
survival proteins ↔
Birc4 protein ↑
Anti-apoptotic
Anti-apoptotic
Rouble et al.,
2013
Aestivation Green-striped burrowing frog (Cyclorana
alboguttata)
fas expression ↑
rassf1 expression ↑
aifm2 expression ↑
birc5 expression ↑
vopp1 expression ↑
htatip2 expression ↑
Pro-apoptotic
Pro-apoptotic
Pro-apoptotic
Anti-apoptotic
Anti-apoptotic
Anti- or pro-
apoptotic
Reilly et al., 2013
African clawed frog (Xenopus laevis) birc2 expression ↑
bcl-xl expression ↑
bcl-2 expression ↑
Birc2 protein ↑
Bcl-xl protein ↑
Bcl-2 protein ↑
Stat5 protein ↑
Anti-apoptotic
Anti-apoptotic
Anti-apoptotic
Anti-apoptotic
Anti-apoptotic
Anti-apoptotic
Anti-apoptotic
Maistrovski,
2011*
West African lungfish (Protopterus
annectens)
TUNEL assay ↑
Nol3 protein ↓
Pro-apoptotic
Anti-apoptotic
Amelio et al.,
2013
*Y. Maistrovski, Regulation of anti-apoptotic pathways in skeletal muscle and liver of an estivating species, Xenopus laevis, MSc thesis, Carleton University,
Ontario, Canada, 2011.
2591
REVIEW Journal of Experimental Biology (2016) 219, 2582-2595 doi:10.1242/jeb.128348
Jo
u
rn
al
o
f
Ex
p
er
im
en
ta
lB
io
lo
g
y
bone loss, artificially immobilised limbs of animals experiencing
metabolic depression should be less prone to atrophy than
immobilised limbs from non-dormant animals. It will also be
important to investigate the role of neural mechanisms in
musculoskeletal sparing in dormant animals; though we are
confident that C. alboguttata is inactive and immobile once the
cocoon of shed skin has been formed during deep aestivation, it
cannot be ruled out that regular neural activation of muscles might
be utilised to protect the musculoskeletal system against disuse-
induced atrophy. However, hibernating bears were reported to be
unusually resistant to the atrophic effects of denervation, indicating
that neural activation and/or neural-associated trophic factors may
not play a significant role in maintaining muscle architecture during
hibernation (Lin et al., 2012). A similar type of response to loss of
neuromuscular communication might be envisaged for aestivators,
given that the quantity of acetylcholine neurotransmitter ‘packages’
(i.e. quanta) released per synapse is reduced in 6 month aestivating
C. alboguttata (Hudson et al., 2005).
To further our understanding of disuse-induced musculoskeletal
loss across vertebrates, and for the possible development and
authentication of new therapies, the use of suitable animal models
continues to be paramount. Although hibernators and aestivators
could be developed into model organisms in this area of biomedical
research, a greater understanding of their biological ‘toolbox’ is
required. This would include the construction of genomes from a
range of species, an extensive catalogue of their genes and
genetic variation, characterisation of different proteomes and
transcriptomes, and the development of bone and muscle cell lines.
Hibernators and aestivators are fascinating study systems that can
provide useful insights into the regulation ofmusculoskeletal integrity
during prolonged disuse, furthering our understanding of both the
basic underlying controls and the responses of the musculoskeletal
system to specific challenges. The common molecular features and
variety of pathways at play during hibernation and aestivation will
hopefully provide new directions for future studies of metabolic
suppression and the associated preservation of muscle and bone.
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